ENOrphanet Journal of Rare Diseases | Nutritional Assessment and Health Risks of Special Low-Protein Foods: A Narrative Review
Date: March 09, 2026
Classification: Frontiers
Recommend:
This article systematically evaluates the nutritional composition of special low-protein foods and their potential health risks for patients with amino acid metabolism disorders, proposing strategies to optimize food formulations using natural ingredients.
Literature Overview
The article 'Assessing the nutritional value and health risks of special low-protein foods: narrative review', published in the Orphanet Journal of Rare Diseases, reviews and summarizes the current applications, nutritional composition, health risks, and improvement strategies of special low-protein foods for patients with amino acid metabolism disorders. The article highlights that although such foods are essential for maintaining metabolic control, their high sugar, high fat, and high additive content may lead to gut microbiota dysbiosis, inflammatory responses, and increased cardiovascular disease risk. It emphasizes the need to enhance nutritional quality through natural plant-based ingredients. The study also calls for the establishment of unified nutritional standards and mandatory labeling systems to safeguard long-term patient health. Furthermore, it suggests that incorporating bioactive components such as resistant starch, prebiotics, probiotics, and polyphenols can improve the nutritional completeness of these foods, support gut health, and reduce chronic disease risks.Background Knowledge
Amino acid metabolism disorders (AMDs) are a group of inherited metabolic diseases, including phenylketonuria (PKU), tyrosinemia (TYR), maple syrup urine disease (MSUD), homocystinuria (HCU), and urea cycle disorders (UCD). Patients must restrict natural protein intake for life to prevent the accumulation of neurotoxic substances, which may lead to intellectual disability, neurological degeneration, or even death. Therefore, special low-protein foods (SLPFs) are a core component of dietary management, providing energy and satiety while avoiding intake of disease-causing amino acids. However, current SLPFs mainly rely on refined starches, hydrogenated oils, and food additives, lacking dietary fiber and micronutrients. Long-term consumption may lead to metabolic syndrome, gut microbiota imbalance, and cardiovascular complications. Although existing research has focused on the nutritional status of PKU patients, systematic assessments of the health impacts of specific SLPF ingredients remain limited. Moreover, there is currently no regulatory oversight of SLPF nutritional composition globally, resulting in inconsistent product quality. Thus, improving the nutritional quality of SLPFs while ensuring safe protein restriction has become a significant challenge in clinical nutrition research. This review fills this gap, providing theoretical and practical guidance for the future development of functional foods.
Research Methods and Experiments
This study employs a narrative review approach, systematically collecting and analyzing observational studies and clinical trials on the nutritional composition, consumption patterns, and health impacts of special low-protein foods (SLPFs). The authors integrated market survey data from Europe, the UK, and Turkey to evaluate the protein, sugar, fat, salt, and food additive content in SLPFs, comparing them with conventional foods. The review also includes mechanistic studies on the effects of food additives (e.g., carrageenan, carboxymethylcellulose, emulsifiers) on gut microbiota, inflammatory markers, and metabolic health, combined with patient cohort data to explore the long-term health burden of consuming SLPFs.Key Conclusions and Findings
Research Significance and Outlook
This study is the first to systematically reveal the potential health risks of special low-protein foods, challenging the traditional notion that 'low-protein equals safe' and emphasizing the need to re-evaluate these medical foods from the perspective of overall nutritional quality. The findings suggest that current SLPF formulations may exacerbate chronic disease risks in patients, particularly regarding cardiovascular and metabolic health.
Future research should focus on developing functional low-protein foods based on natural plant ingredients, such as green banana flour, chicory root, and purple sweet potato—rich in resistant starch and polyphenols—as alternatives to refined starches and artificial additives. Long-term intervention trials are also needed to validate the effects of new formulations on gut microbiota, inflammatory markers, and metabolic indicators.
In addition, international regulatory agencies should be encouraged to establish minimum nutritional standards for SLPFs, requiring mandatory labeling of additive types and contents to protect patient rights and health. Clinical dietitians should also provide more personalized dietary guidance to patients, avoiding excessive reliance on processed SLPFs.
Conclusion
This article provides a systematic review of the central role and potential health risks of special low-protein foods (SLPFs) in the dietary management of patients with amino acid metabolism disorders. Although SLPFs effectively support protein-restricted diets, their high sugar, high fat, and high additive formulations may trigger gut microbiota dysbiosis, chronic inflammation, and cardiovascular disease risks. The study finds that widely used food additives such as carrageenan and carboxymethylcellulose can disrupt the gut barrier, suppress beneficial bacteria, and promote metabolic syndrome development. Meanwhile, SLPFs generally lack vitamins and minerals, and long-term dependence may lead to micronutrient deficiencies. To improve the current situation, the authors propose enhancing nutritional completeness by incorporating bioactive ingredients such as resistant starch, prebiotics, probiotics, polyphenols, and natural colorants. Additionally, they call for the establishment of unified nutritional standards and mandatory labeling systems to protect long-term patient health. This review provides scientific evidence for optimizing SLPF formulations, emphasizing that future medical food development must balance safety and nutritional quality to truly achieve the health goals of 'therapeutic diets'.
